Amerise Biosciences

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue1.840.005.650.000.00
Expenses1.520.036.280.040.01
EBITDA0.32-0.03-0.63-0.04-0.01
EBIT0.32-0.03-0.63-0.04-0.01
Profit Before Tax0.33-0.370.29-0.04-0.01
Net Profit0.33-0.370.29-0.04-0.01
Financial Ratios
Operating Profit Margin17.39%NA%-11.15%NA%NA%
Net Profit Margin17.93%NA%5.13%NA%NA%
Earning Per Share (Diluted)0.05-0.060.04-0.01-0.00
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.6.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI